FI935073L - Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar - Google Patents

Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar Download PDF

Info

Publication number
FI935073L
FI935073L FI935073A FI935073A FI935073L FI 935073 L FI935073 L FI 935073L FI 935073 A FI935073 A FI 935073A FI 935073 A FI935073 A FI 935073A FI 935073 L FI935073 L FI 935073L
Authority
FI
Finland
Prior art keywords
thiopyranopyrol
farmaceutiska
sammansaettningar
nya
framstaellning
Prior art date
Application number
FI935073A
Other languages
English (en)
Finnish (fi)
Other versions
FI935073A0 (fi
FI935073A7 (fi
Inventor
Daniel Achard
Claude Moutonnier
Jean-Francois Peyronel
Michel Tabart
Alain Truchon
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI935073A0 publication Critical patent/FI935073A0/fi
Publication of FI935073A7 publication Critical patent/FI935073A7/fi
Publication of FI935073L publication Critical patent/FI935073L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI935073A 1991-05-17 1992-05-15 Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar FI935073L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9106037A FR2676446B1 (fr) 1991-05-17 1991-05-17 Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
PCT/FR1992/000431 WO1992020685A1 (fr) 1991-05-17 1992-05-15 Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
FI935073A0 FI935073A0 (fi) 1993-11-16
FI935073A7 FI935073A7 (fi) 1993-11-16
FI935073L true FI935073L (fi) 1993-11-16

Family

ID=9412909

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935073A FI935073L (fi) 1991-05-17 1992-05-15 Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar

Country Status (17)

Country Link
EP (2) EP0514275A1 (cs)
JP (1) JPH06507894A (cs)
AU (1) AU653033B2 (cs)
CA (1) CA2109296A1 (cs)
CZ (1) CZ244993A3 (cs)
FI (1) FI935073L (cs)
FR (1) FR2676446B1 (cs)
HU (1) HUT70490A (cs)
IE (1) IE921543A1 (cs)
IL (1) IL101864A0 (cs)
MX (1) MX9202289A (cs)
NO (1) NO934146D0 (cs)
NZ (1) NZ242737A (cs)
SK (1) SK126993A3 (cs)
TW (1) TW201748B (cs)
WO (1) WO1992020685A1 (cs)
ZA (1) ZA923513B (cs)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676447B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveaux derives du thiopyranopyrrole et leur preparation.
FR2725900B1 (fr) * 1994-10-21 1997-07-18 Sanofi Sa Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
FR2741262B1 (fr) 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
FR2777566B1 (fr) 1998-04-15 2003-02-21 Synthelabo Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
ES2304984T3 (es) 1999-11-03 2008-11-01 Amr Technology, Inc. Tetra-hidroisoquinolinas de sustitucion arilica y heteroarilica y su utilizacion para bloquear la recaptacion de norepinefrina, dopamina y serotonina.
US7084152B2 (en) 2000-07-11 2006-08-01 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
MX2007000428A (es) 2004-07-15 2008-03-05 Amr Technology Inc Tetrahidroisoquinolinas sustituidas con arilo y heteroarilo y uso de las mismas para bloquear la captacion de norepinefrina, dopamina y serotonina.
EP1888050B1 (en) 2005-05-17 2012-03-21 Merck Sharp & Dohme Ltd. cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid for the treatment of cancer
WO2007011820A2 (en) 2005-07-15 2007-01-25 Amr Technology, Inc. Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
SI2805945T1 (sl) 2007-01-10 2019-09-30 Msd Italia S.R.L. Amid substituirani indazoli, kot inhibitorji poli(ADP-riboza)polimeraze(PARP)
JP2010516731A (ja) 2007-01-24 2010-05-20 グラクソ グループ リミテッド ２−メトキシ−５−（５−トリフルオロメチル−テトラゾール−１−イル）−ベンジル］−（２ｓ−フェニル−ピペリジン−３ｓ−イル）−アミンを含む医薬組成物
JP5501227B2 (ja) 2007-06-27 2014-05-21 メルク・シャープ・アンド・ドーム・コーポレーション ヒストンデアセチラーゼ阻害剤としての４−カルボキシベンジルアミノ誘導体
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
AR071997A1 (es) 2008-06-04 2010-07-28 Bristol Myers Squibb Co Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
ES2446971T3 (es) 2009-05-12 2014-03-11 Albany Molecular Research, Inc. Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
CN102638982B (zh) 2009-05-12 2015-07-08 百时美施贵宝公司 (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途
MX2011011907A (es) 2009-05-12 2012-01-20 Albany Molecular Res Inc 7-([1,2,4,]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2, 3,4-tetrahidroisoquinolina y uso de la misma.
EA023838B1 (ru) 2009-10-14 2016-07-29 Мерк Шарп Энд Домэ Корп. ЗАМЕЩЕННЫЕ ПИПЕРИДИНЫ, КОТОРЫЕ ПОВЫШАЮТ АКТИВНОСТЬ p53, И ИХ ПРИМЕНЕНИЕ
US8518907B2 (en) 2010-08-02 2013-08-27 Merck Sharp & Dohme Corp. RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
RU2745848C2 (ru) 2010-08-17 2021-04-01 Сирна Терапьютикс, Инк. ОПОСРЕДУЕМОЕ РНК-ИНТЕРФЕРЕНЦИЕЙ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ ГЕНОВ ВИРУСА ГЕПАТИТА B (HBV) С ПРИМЕНЕНИЕМ МАЛОЙ ИНТЕРФЕРИРУЮЩЕЙ НУКЛЕИНОВОЙ КИСЛОТЫ (миНК)
US8883801B2 (en) 2010-08-23 2014-11-11 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
EP2613782B1 (en) 2010-09-01 2016-11-02 Merck Sharp & Dohme Corp. Indazole derivatives useful as erk inhibitors
US9242981B2 (en) 2010-09-16 2016-01-26 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel ERK inhibitors
US9260471B2 (en) 2010-10-29 2016-02-16 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
US9351965B2 (en) 2010-12-21 2016-05-31 Merck Sharp & Dohme Corp. Indazole derivatives useful as ERK inhibitors
US20140045847A1 (en) 2011-04-21 2014-02-13 Piramal Enterprises Limited Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
WO2013063214A1 (en) 2011-10-27 2013-05-02 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
EP3358013B1 (en) 2012-05-02 2020-06-24 Sirna Therapeutics, Inc. Short interfering nucleic acid (sina) compositions
JP6280554B2 (ja) 2012-09-28 2018-02-14 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Ｅｒｋ阻害剤である新規化合物
PT2925888T (pt) 2012-11-28 2017-12-13 Merck Sharp & Dohme Composições e métodos para tratamento do cancro
EP2935263B1 (en) 2012-12-20 2018-12-05 Merck Sharp & Dohme Corp. Substituted imidazopyridines as hdm2 inhibitors
WO2014120748A1 (en) 2013-01-30 2014-08-07 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as hdm2 inhibitors
CN103317438B (zh) * 2013-06-18 2015-08-19 浙江工业大学 动压浮离抛光盘动压浮离位置精密调整机构
WO2015034925A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Circular polynucleotides
US10975084B2 (en) 2016-10-12 2021-04-13 Merck Sharp & Dohme Corp. KDM5 inhibitors
WO2019094311A1 (en) 2017-11-08 2019-05-16 Merck Sharp & Dohme Corp. Prmt5 inhibitors
US11098059B2 (en) 2017-11-08 2021-08-24 Merck Sharp & Dohme Corp. PRMT5 inhibitors
EP3833667B1 (en) 2018-08-07 2024-03-13 Merck Sharp & Dohme LLC Prmt5 inhibitors
US11993602B2 (en) 2018-08-07 2024-05-28 Merck Sharp & Dohme Llc PRMT5 inhibitors
CA3108388A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042707A (en) * 1976-02-19 1977-08-16 E. I. Du Pont De Nemours And Company 3α-Arylhydroisoindoles
EP0093805B1 (en) * 1981-02-17 1987-05-13 Warner-Lambert Company Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1h-isoindole-1-carboxylic acids and esters
US4439229A (en) * 1981-06-29 1984-03-27 Rohm And Haas Company Substituted phthalimides herbicides
FR2676447B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveaux derives du thiopyranopyrrole et leur preparation.

Also Published As

Publication number Publication date
FR2676446A1 (fr) 1992-11-20
FI935073A0 (fi) 1993-11-16
IE921543A1 (en) 1992-11-18
JPH06507894A (ja) 1994-09-08
SK126993A3 (en) 1994-11-09
TW201748B (cs) 1993-03-11
EP0586486A1 (fr) 1994-03-16
CA2109296A1 (fr) 1992-11-18
NZ242737A (en) 1993-06-25
AU1914092A (en) 1992-12-30
NO934146L (no) 1993-11-16
HUT70490A (en) 1995-10-30
IL101864A0 (en) 1992-12-30
FR2676446B1 (fr) 1993-08-06
ZA923513B (en) 1993-02-24
EP0514275A1 (fr) 1992-11-19
HU9303252D0 (en) 1994-03-28
AU653033B2 (en) 1994-09-15
MX9202289A (es) 1993-02-01
WO1992020685A1 (fr) 1992-11-26
FI935073A7 (fi) 1993-11-16
CZ244993A3 (en) 1994-03-16
NO934146D0 (no) 1993-11-16

Similar Documents

Publication Publication Date Title
FI935073L (fi) Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar
FI935074L (fi) Nya tiopyranopyrrolderivat och framstaellning av dem
FI935174L (fi) Tumoeravstoetande antigenprekursorer, tumoeravstoetande antigener och anvaendning av dem
FI922474L (fi) Nedbrytbara sulfonatgrupphaltiga kelatmedel, anvaendning av dem och kompositioner innehaollande dem
FI934000L (fi) Nya estrar av bi- och tricykliska aminoalkoholer, deras framstaellning och deras anvaendning i laekemedel
FI935421A7 (fi) Konstruktionsdel av plaot, byggnadspanel och byggnadsfoerfarande
FI935189A7 (fi) Glasfiberarmerad plastbehaollare, foerfarande och anordning foet tillverkning av en saodan behaollare
FI921201L (fi) Klibbija, hydrofila gelfoerband och av dem framstaellda produkter
FI931476A7 (fi) Indolinderivat med en amidfunktionell grupp, framstaellning av dem och dessa innehaollande farmaceutiska kompositioner
FI925735L (fi) Polymerer och oligomerer av gallsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI925174L (fi) Nya organokiselfoereningar och kompositioner innehaollande dem
FI923143L (fi) Homogeniska, stabila och flytande vattenblandningar och anvaendning av naemnda blandningar foer framstaellning av dispersioner av i vatten oloesliga substanser
FI920732L (fi) 2-substituerade kinoliner, foerfarande foer framstaellning av dessa och anvaendning av dessa i laekemedel
FI932255L (fi) Alkalinproteaser, bakterier producerande dem, foerfarande foer framstaellning av dessa alkalinproteaser, anvaendning av dessa alkalinproteaser och tvaettmedelskompositioner innehaollande dem
FI914611A0 (fi) 2-aminopyrimidin-4 -karboxamidderivat, framstaellning och terapeutisk anvaendning av dem.
FI925946L (fi) Nya 2-sackarinylmetylaryl- och -aryloxiacetat anvaendbara som inhibitorer foer proteolytiska ensymer, kompositioner innehaollande dessa och anvaendning av dessa
FI920349L (fi) Foerfarande foer framstaellning av nya tetrazolderivat och deras anvaendning.
FI924617A7 (fi) Anordning foer viktinstaellning av instaellning av sittyta och ryggstoed istolar, saerskilt byrosvaengstolar
FI923170A7 (fi) Spicamycinderivat och anvaendning av dem
FI933544L (fi) Tiadiazinkarboxamidderivat, foerfaranden foer framstaellning av dem och laekemedel
FI923755L (fi) Disulfider, foerfarande foer framstaellning av dessa och anvaendning av dessa
FI921340L (fi) Nya tiazolidinon- och oxazolidinonderivat, deras framstaellning och anvaendning som utvidgare av blodkaerlen
FI922867A0 (fi) Dikarbonsyraderivat och foerfarande foer framstaellning av dem.
FI920720A7 (fi) 4-pyrimidinonderivat, framstaellning av dessa och anvaendning av dessa iterapi
FI935845L (fi) Formskiva, kontaktskikt och foerfarande foer tillverkning av formskivan

Legal Events

Date Code Title Description
FD Application lapsed